Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival

被引:77
作者
Jain, AN
Chin, K
Borresen-Dale, AL
Erikstein, BK
Lonning, PE
Kaaresen, R
Gray, JW
机构
[1] Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA
[2] Norwegian Radium Hosp, Inst Canc Res, Dept Genet & Oncol, N-0310 Oslo, Norway
[3] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway
[4] Ulleval Hosp, Dept Surg, N-0407 Oslo, Norway
关键词
D O I
10.1073/pnas.151241198
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We present a general method for rigorously identifying correlations between variations in large-scale molecular profiles and outcomes and apply it to chromosomal comparative genomic hybridization data from a set of 52 breast tumors. We identify two loci where copy number abnormalities are correlated with poor survival outcome (gain at 8q24 and loss at 9q13), We also identify a relationship between abnormalities at two loci and the mutational status of p53, Gain at 8q24 and loss at 5q15-5q21 are linked with mutant p53, The 9q and 5q losses suggest the possibility of gene products involved in breast cancer progression. The analytical techniques are general and also are applicable to the analysis of array-based expression data.
引用
收藏
页码:7952 / 7957
页数:6
相关论文
共 17 条
[1]   Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].
Aas, T ;
Borresen, AL ;
Geisler, S ;
SmithSorensen, B ;
Johnsen, H ;
Varhaug, JE ;
Akslen, LA ;
Lonning, PE .
NATURE MEDICINE, 1996, 2 (07) :811-814
[2]   Probing lymphocyte biology by genomic-scale gene expression analysis [J].
Alizadeh, A ;
Eisen, M ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (06) :373-379
[3]   PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA [J].
ANDERSEN, TI ;
HOLM, R ;
NESLAND, JM ;
HEIMDAL, KR ;
OTTESTAD, L ;
BORRESEN, AL .
BRITISH JOURNAL OF CANCER, 1993, 68 (03) :540-548
[4]   ALTERATIONS OF THE TP53 GENE AS A POTENTIAL PROGNOSTIC MARKER IN BREAST CARCINOMAS - ADVANTAGES OF USING CONSTANT DENATURANT GEL-ELECTROPHORESIS IN MUTATION DETECTION [J].
ANDERSEN, TI ;
BORRESEN, AL .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1995, 4 (03) :203-211
[5]  
BERNS EMJJ, 1992, CANCER RES, V52, P1107
[6]   INVIVO AMPLIFICATION AND REARRANGEMENT OF C-MYC ONCOGENE IN HUMAN-BREAST TUMORS [J].
BONILLA, M ;
RAMIREZ, M ;
LOPEZCUETO, J ;
GARIGLIO, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (09) :665-671
[7]  
Bukholm IK, 1997, J PATHOL, V181, P140, DOI 10.1002/(SICI)1096-9896(199702)181:2<140::AID-PATH745>3.0.CO
[8]  
2-A
[9]  
CAREY R, 1997, VRML VIRTUAL REALITY
[10]  
DEVRIES S, 1995, CURRENT PROTOCOLS HU, P1